ABSTRACT
OBJECTIVE： To evaluate the economic effectiveness of different pharmacotherapeutic schemes for the same disease Three therapeutic schemes（ including A， B and C schemes） for peptic ulcer with Helicobacteria pylori were compared METHODS： The schemes were evaluated with pharmacoeconomic cost－ effectiveness analysis RESULTS： The results showed that B was the best scheme from either cost－ effectiveness analysis（ C/E） or increasing costeffectiveness analysis（ Δ C/Δ E） CONCLUSION： Pharmacoeconomics is very important in optimizing therapeutic scheme， guiding rational drug use and in_ creasing economic effectiveness
ABSTRACT
OBJECTIVE:To evaluate the economic effectiveness of different pharmacotherapeutic schemes for the same disease Three therapeutic schemes(including A,B and C schemes)for peptic ulcer with Helicobacteria pylori were compared METHODS:The schemes were evaluated with pharmacoeconomic cost-effectiveness analysis RESULTS:The results showed that B was the best scheme from either cost-effectiveness analysis(C/E)or increasing costeffectiveness analysis(?C/?E) CONCLUSION:Pharmacoeconomics is very important in optimizing therapeutic scheme,guiding rational drug use and in_creasing economic effectiveness